Supreme Court Rejects Challenge to Abortion Drug Mifepristone

Lower courts previously ruled the government improperly rolled back safety-related restrictions on the drug.

The Supreme Court in Washington on April 25, 2024. Mandel Ngan/AFP/Getty Images

The Supreme Court unanimously rejected a challenge on June 13 that was brought by a doctors’ group against the Food and Drug Administration’s (FDA’s) loosening of regulations of the abortion pill mifepristone, handing a win to the agency.

The court held that those challenging the status of the pill lacked the legal standing to do so.